SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-034462
Filing Date
2019-02-12
Accepted
2019-02-11 21:23:02
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2016 GP, L.L.C.GV 2016 GP, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d658521dsc13g.htm SC 13G 120998
2 EX-A d658521dex99a.htm EX-99.A 8526
  Complete submission text file 0001193125-19-034462.txt   131182
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90538 | Film No.: 19587410
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2016, L.P. (Filed by) CIK: 0001721789 (see all company filings)

IRS No.: 611775632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G